PE  Resilience Capital Partners

     Office Locations:

25101 Chagrin Boulevard, Suite 350
Cleveland, OH 44122
Phone: 216-292-0200
Fax: 216-292-4750



  • Middle Market



  • Manufacturing & Industrial
  • Retail & Restaurant
  • Transportation & Distribution



    Resilience Capital Partners is a private equity firm focused on principal investing in lower middle market underperforming and turnaround situations. Resilience is focused on making control equity, and on occasion minority, investments in companies that have solid fundamental business prospects but have suffered from a cyclical industry downturn, are over-leveraged, or have less than adequate management resources. Resilience typically invests in basic industry businesses with revenues of $25 million to $250 million, and EBITDA typically under $20 million. Resilience makes equity investments of $10 to $75 million in a wide range of industries. Resilience will invest in the Automotive, Basic Manufacturing, Capital Goods, Chemicals, Plastics, Metals and Metal Fabrication, Retail, Transportation, Packaging, and Distribution sectors. The Resilience Executive Advisor Network and Resilience Innovation and Technology team consists of more than 50 advisors who are established business leaders with experience from different industries and regions from around the world.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Bassem Mansour Co-Founder and Co-CEO
    Chad Hesse General Counsel & Co-Chief Compliance Officer
    Chris Clair Chief Financial Officer & Co-Chief Compliance Officer
    Corey Feller Senior Associate
    David Glickman Partner


    Recent Funding Events (trailing 12 months):







      Garuda Therapeutics



      Series A


    Portfolio companies include:


    Recent News: